Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04987580 · ClinicalTrials.gov registry record
Efficacy and Safety of a Single Syringe Total Intravenous Anesthesia With Propofol and Remifentanil: A Prospective Cohort Study
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 125
- Enrollment target
NCT04987580 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 125 participants.
The verdict
NCT04987580 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 125 participants
- Enrollment target
Study Summary
The purpose of this prospective observational study was to evaluate the efficacy and safety of single syringe TIVA with propofol and remifentanil. The primary outcome for efficacy was a processed EEG (pEEG) index within the recommended range for general anesthesia for the duration of the maintenance anesthetic. The primary outcome measure for safety was intraoperative administration of vasopressors. We hypothesized that the pEEG index would be within the recommended range for over 90% of the duration of the maintenance anesthetic. We hypothesized that vasopressor use would be consistent with other anesthetic types using potent inhaled agents.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2023-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04987580
The ClinicalTrials.gov registry entry for NCT04987580 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04987580 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04987580 about?
NCT04987580 is a clinical study titled "Efficacy and Safety of a Single Syringe Total Intravenous Anesthesia With Propofol and Remifentanil: A Prospective Cohort Study". The purpose of this prospective observational study was to evaluate the efficacy and safety of single syringe TIVA with propofol and remifentanil. The primary outcome for efficacy was a processed EEG (pEEG) index within the recommended range for general anesthesia for the duration of the maintenance...
What is the current status of trial NCT04987580?
This trial is currently completed. The enrollment target is 125 participants. The study started on 2021-06-01. Estimated completion is 2023-06-30.
Who is sponsoring clinical trial NCT04987580?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.